Effect of Atorvastatin on Wound Healing in Rats

Biological Research for Nursing

Volumn 17, Issue 2, 2015, Pages 159-168

  Suzuki Banhesse, Vanessa Ferraz ^a   Azevedo, Flávia Figueiredo ^a   Araujo, Eliana Pereira ^a   do Amaral, Maria Esméria Corezola ^b   Caricilli, Andrea Moro ^c   Saad, Mario Jose Abdalla ^a   Lima, Maria Helena Melo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b CENTRO UNIVERSITÁRIO HERMÍNIO OMETTO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

hydroxymethylglutaryl CoA reductase inhibitors; nursing; wound healing

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN-1BETA (163-171); MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE FRAGMENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANIMAL; DRUG EFFECTS; IMMUNOBLOTTING; MALE; ORAL DRUG ADMINISTRATION; RAT; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ATORVASTATIN CALCIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOBLOTTING; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, INSULIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84922939396     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800414537348     Document Type: Article

References (26)

1. Adami M.,Prudente A. A. S.,Mendes D. A.,Horinouchi C. D.,Cabrini D. A.,Otuki M. F.Simvastatin ointment, a new treatment for skin inflammatory conditions.Journal of Dermatological Science. 2012;66:127-135
2. Araújo F. A.,Rocha M. A.,Mendes J. B.,Andrade S. P.Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1.Biomedicine & Pharmacotherapy. 2010;64:29-34
3. Asai J.,Takenaka H.,Hirakawa S.,Sakabe J.,Hagura A.,Kishimoto S.,Katoh N.Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.American Journal of Pathology. 2012;181:2217-2224
4. Bao P.,Kodra A.,Tomic-Canic M.,Golinko M. S.,Ehrlich H. P.,Brem H.The role of vascular endothelial growth factor in wound healing.Journal of Surgical Research. 2009;153:347-358
5. Bitto A.,Minutoli L.,Altavilla D.,Polito F.,Fiumara T.,Marini H.,Squadrito F.Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes.Pharmacological Research. 2008;57:159-169
6. Bracht L.,Caparroz-Assef S. M.,Magon T. F.,Ritter A. M.,Cuman R. K.,Bersani-Amado C. A.Topical anti-inflammatory effect of hypocholesterolaemic drugs.Journal of Pharmacological Research. 2011;63:971-975
7. Calisto K. L.,Carvalho B. E. M.,Ropelle E. R.,Mittestainer F. C.,Camacho A. C.,Guadagnini D.,Saad M. J.Atorvastatin improves survival in septic rats: Effect on tissue inflammatory pathway and on insulin signaling.PLoS One. 2010;5:e14232
8. Danesh F. R.,Kanwar Y. S.Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.The FASEB Journal. 2004;18:805-815
9. Efthymiou C. A.,Mocanu M. M.,Yellon D. M.Atorvastatin and myocardial reperfusion injury: New pleiotropic effect implicating multiple prosurvival signaling.Journal of Cardiovascular Pharmacology. 2005;45:247-252
10. Eming S. A.,Krieg T.,Davidson J. M.Inflammation in wound repair: Molecular and cellular mechanisms.Journal of Investigative Dermatology. 2007;127:514-525
11. Johansen O. E.,Birkeland K. I.,Jorgensen E. O.,Sorgard B.,Torjussen B. R.,Ueland T.Gullestad L.Diabetic foot ulcer burden may be modified by high dose atorvastatin: A 6-month randomized controlled pilot trial.Journal of Diabetes. 2009;1:182-187
12. Jowkar F.,Namazi M. R.Statins in dermatology.International Journal of Dermatology. 2010;49:1235-1243
13. Kaehn K.An in-vitro model for comparing the efficiency of wound-rinsing solutions.Journal of Wound Care, 18. 2009;232 (234): 229-230
14. Karadeniz Cakmak G.,Irkorucu O.,Ucan B. H.,Emre A. U.,Bahadir B.,Demirtas C.,Comert M.Simvastatin improves wound strength after intestinal anastomosis in the rat.Journal of Gastrointestinal Surgery. 2009;13:1707-1716
15. Kwak B.,Mulhaupt F.,Myit S.,Mach F.Statins as a newly recognized type of immunomodulator.Nature Medicine. 2000;6:1399-1402
16. Laing T.,Hanson R.,Chan F.,Bouchier-Hayes D.Effect of pravastatin on experimental diabetic wound healing.Journal of Surgical Research. 2010;161:336-340
17. Liao J. K.,Laufs U.Pleiotropic effects of statins.Annual Review of Pharmacology and Toxicology. 2005;45:89-118
18. Lima M. H. M.,Caricilli A. M.,de Abreu L. L.,Araújo E. P.,Pelegrinelli F. F.,Thirone A. C. P.Saad M. J. A.Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: A double-blind placebo-controlled clinical trial.PLoS ONE. 2012;7:e36974
19. Pastore S.,Mascia F.,Mariotti F.,Dattilo C.,Mariani V.,Girolomoni G.ERK1/2 regulates epidermal chemokine expression and skin inflammation.Journal of Immunology. 2005;174:5047-5056
20. Reagan-Shaw S.,Nihal M.,Ahmad N.Dose translation from animal to human studies revisited.The FASEB Journal. 2008;22:659-661
21. Rodionova E.,Conzelmann M.,Maraskovsky E.,Hess M.,Kirsch M.,Giese T.,Luft T.GSK-3 mediates differentiation and activation of proinflammatory dendritic cells.Blood. 2007;109:1584-1592
22. Schiefelbein D.,Goren I.,Fisslthaler B.,Schmidt H.,Geisslinger G.,Pfeilschifter J.,Frank S.Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses.Journal of Biological Chemistry. 2008;283:15479-15490
23. Stumpf C.,Petzi S.,Seybold K.,Wasmeier G.,Arnold M.,Raaz D.,Garlichs C. D.Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.Clinical Science. 2009;116:45-52
24. Toker S.,Gulcan E.,Cayc M. K.,Olgun E. G.,Erbilen E.,Ozay Y.Topical atorvastatin in the treatment of diabetic wounds.American Journal of the Medical Sciences. 2009;338:201-204
25. Van Linthout S.,Riad A.,Dhayat N.,Spillmann F.,Du J.,Dhayat S.,Tschöpe C.Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.Diabetologia. 2007;50:1977-1986
26. Waiczies S.,Prozorovski T.,Infante-Duarte C.,Hahner A.,Aktas O.,Ullrich O.,Zipp F.Atorvastatin induces T cell anergy via phosphorylation of ERK1.Journal of Immunology. 2005;174:5630-5635